Israeli Protein Separation Startup Obtains $14 Million in Financing

Mar 05, 2001

NEW YORK, March 5 – Proteologics, a proteomics startup in Rehovot, Israel, has obtained $14 million in financing from venture capital firms, the company said Monday.

Concord Ventures, also based in Israel, led the financing with $9 million, with U.S .Venture Capital firm ABS Ventures and the Giza Fund, one of Israel's largest venture capital groups, supplying the remainder.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in PNAS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

Choice Against Testing

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

Call for Gene Editing Oversight

The Japan Times says regulations are needed to oversee human genome-editing research.

This Week in PLOS

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Main menu